PubMed Health⌕ Search

Biomedical subjects

Kazuhiro Tamura

Publications and source records attributed to Kazuhiro Tamura.

20 records · Page 2Linked to original sources

Temporal expression of type I interferon receptor in the peri-implantation ovine extra-embryonic membranes: demonstration that human IFNalpha can bind to this receptor.

Interferon-tau (IFNtau), produced by the trophectoderm of ruminant ungulates, binds to the type I IFN receptor (IFNAR) located at the uterine endometrium in a paracrine manner. Since IFNtau attenuates the secretory pattern of an endometrial luteolysin, prostaglandin F2alpha, IFNtau has been considered as a conceptus factor implicated in the process of maternal recognition of pregnancy. Here we report the presence of IFNAR subunit (IFNAR1) in ovine conceptuses during the period of peri-implantation development and demonstrate that 125I-human (h) IFNalpha binds to membrane preparations from ovine corpus luteum and conceptus. Using an antibody against hIFNAR1, immunohistochemical analysis revealed that IFNAR1 protein was present in day 14 and 16 conceptuses (day 0 = day of estrus) and luminal and glandular epithelia of the endometrium. Conceptus membrane proteins analyzed by western blot with the same antibody displayed immunoreactive bands at 95, 60 and 55 kDa while endometrial membrane proteins showed bands at 200, 95 and 55 kDa. Northern blot analysis revealed that IFNAR1 mRNA was present in days 15-19 conceptuses and day 18-19 allantoic membranes. Receptor binding studies indicated that 125I-hIFNalpha binding to day 16, but not earlier, conceptus membrane proteins could be displaced with hIFNalpha or ovine IFNtau. Based on Scatchard analysis, day 16 conceptus membranes contained 28 fmol IFNAR/mg protein with a dissociation constant of 300 pM. Cross-linking experiments demonstrated that 125I-hIFNalpha-receptor complex migrated at 120 kDa, indicating that the receptor component(s) was approximately 100 kDa. These data provide evidence that although the binding does not occur until day 16, ovine conceptuses possess IFNAR1 near or at the time of implantation, suggesting that IFNtau, a factor produced by the trophectoderm of ruminant ungulates, could act on the conceptus in an autocrine manner. In addition to functioning as an antiluteolytic factor, therefore, IFNtau may have a direct effect on conceptus development.

Animals↗

[Suppressive effects of bisphosphonates on the vascular calcification in ESRD patients].

The progress of aortic calcification is associated with the incidence of cardiac and cerebrovascular diseases in hemodialysis patients. The present study was designed to determine whether etidronate can affect the development of aortic calcification in hemodialysis patients. Etidronate was given orally just before sleep on the day of dialysis, which was performed 2 or 3 sessions per week. Aortic calcification area (ACA), bone mineral density (BMD), and biochemical parameters were measured 6 months after the start of etidronate treatment to them compare with control. ACA in the control group showed a statistically significant increase after 6 months. However, the patients who received etidronate had no significant changes in ACA. Clinical and biochemical parameters and BMD were not influenced by etidronate treatment except serum alkaline phosphatase. These results suggest that etidronate has a potential ability to inhibit the progression of vascular calcification in hemodialysis patients, and that this beneficial effect of etidronate may prevent cardiovascular and cerebrovascular diseases that are major causes of death in hemodialysis patients.

English Abstract↗